Diversified Trust’s Provectus Biopharmaceuticals PVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PVCT
AW
Diversified Trust's PVCT Position: Q4 2022 in Review
Diversified Trust sold out of Provectus Biopharmaceuticals (PVCT) in Q4 2022, closing a stake of 50,000 shares — an estimated $2K sold.
Diversified Trust first reported a position in PVCT in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q2 2022. 7 funds tracked by Wall St. Rank hold PVCT as of Q4 2022.
- Diversified Trust reported no remaining Provectus Biopharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Diversified Trust sold 50,000 Provectus Biopharmaceuticals shares in Q4 2022, an estimated $2K.
- Diversified Trust first reported a position in Provectus Biopharmaceuticals in Q2 2022 and held it in 2 quarters.
- Diversified Trust's Provectus Biopharmaceuticals position peaked at $3K in Q2 2022.
- 7 funds tracked by Wall St. Rank held Provectus Biopharmaceuticals as of Q4 2022.
Based on Diversified Trust's 13F filing for Q4 2022, filed 17 Jan 2023.